I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 42 800 VND Market Closed
Market Cap: 6.6T VND
Have any thoughts about
Imexpharm Corp?
Write Note

Imexpharm Corp
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Imexpharm Corp
Interest Income Expense Peer Comparison

Comparables:
H
DHT
C
DCL
D
DMC
D
DHG
T
TRA

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
I
Imexpharm Corp
VN:IMP
Interest Income Expense
â‚«7.8B
CAGR 3-Years
12%
CAGR 5-Years
-11%
CAGR 10-Years
-4%
H
HaTay Pharmaceutical JSC
VN:DHT
Interest Income Expense
-â‚«1.2B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
7%
C
Cuu Long Pharmaceutical JSC
VN:DCL
Interest Income Expense
â‚«6.4B
CAGR 3-Years
-45%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Interest Income Expense
â‚«33.5B
CAGR 3-Years
65%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Interest Income Expense
â‚«139.8B
CAGR 3-Years
15%
CAGR 5-Years
0%
CAGR 10-Years
14%
T
Traphaco JSC
VN:TRA
Interest Income Expense
â‚«23.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Imexpharm Corp's Interest Income Expense?
Interest Income Expense
7.8B VND

Based on the financial report for Jun 30, 2024, Imexpharm Corp's Interest Income Expense amounts to 7.8B VND.

What is Imexpharm Corp's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-4%

Over the last year, the Interest Income Expense growth was -52%. The average annual Interest Income Expense growth rates for Imexpharm Corp have been 12% over the past three years , -11% over the past five years , and -4% over the past ten years .

Back to Top